Gabriel invests in Novosound, along with lead investor Par Equity
Novosound is the first spin-out company to emerge from the University of the West of Scotland. They were the winners of the 2017 Converge Challenge, and have developed and patented a ground-breaking technique to mass-manufacture printable ultrasound sensors. The revolutionary method overcomes the limitations of existing technology, improving a manufacturing process, which hasn’t majorly changed in more than 40 years.
The investment is lead by Par Equity, the Edinburgh-based venture capital firm which has a strong track record in investing in early stage companies. Since securing funding from the Gabriel Syndicate, Novosound has been able to drive its growth plan, allowing them to expand its team and bring its cutting-edge ultrasound sensors to market.